Cellular and Molecular Life SciencesMolecular BiologyPeer-reviewed journal article
Clustered PHD domains in KMT2/MLL proteins are attracted by H3K4me3 and H3 acetylation-rich active promoters and enhancers
Anna Stroynowska-CzerwińskaiD, Magdalena KlimczakiD, Michal PástoriD, Asgar Abbas KazraniiD, Katarzyna MisztaliD, Matthias BochtleriD
Abstract
Histone lysine-specfic methyltransferase 2 (KMT2A-D) proteins, alternatively called mixed lineage leukaemia (MLL1-4) proteins, mediate positive transcriptional memory. As the catalytic subunits of human COMPASS-like complexes, they methylate H3K4 at promoters and enhancers. KMT2A-D contain understudied highly conserved triplets and a quartet of plant homeodomains (PHDs). Here, we show that all clustered PHDs localise to the well-defined loci of H3K4me3 and H3 acetylation-rich active promoters and enhancers. Surprisingly, we observe little difference in binding pattern between PHDs from promoter-specific KMT2A-B and enhancer-specific KMT2C-D. Fusion of the KMT2A CXXC domain to the PHDs drastically enhances their preference for promoters over enhancers. Hence, the presence of CXXC domains in KMT2A-B, but not KMT2C-D, may explain the promoter/enhancer preferences of the full-length proteins. Importantly, targets of PHDs overlap with KMT2A targets and are enriched in genes involved in the cancer pathways. We also observe that PHDs of KMT2A-D are mutated in cancer, especially within conserved folding motifs (Cys4HisCys2Cys/His), which cause a domain loss-of-function. Taken together, our data suggests that PHDs of KMT2A-D guide the full-length proteins to active promoters and enhancers, and thus play a role in positive transcriptional memory. GRAPHICAL ABSTRACT O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=123 SRC="FIGDIR/small/462366v2_ufig1.gif" ALT="Figure 1"> View larger version (30K): org.highwire.dtl.DTLVardef@1d62842org.highwire.dtl.DTLVardef@ed1041org.highwire.dtl.DTLVardef@1c62b43org.highwire.dtl.DTLVardef@1426bcd_HPS_FORMAT_FIGEXP M_FIG C_FIG
- Citations
- 14
- FWCI
- 1.24
- Field percentile
- top 23%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- The nuclear oncoprotein SET is necessary for MLL/KMT2A binding and transcriptional elongation.
María-Paz García-Cuéllar, Robert K. Slany·bioRxiv·Feb 28, 2026
- Fbxl10/Kdm2b is required for Kmt2b/Mll2 binding across thegenome and regulates H3K4 methylation on bivalent promoters
Fei Ji, Sharmistha Kundu, … Ruslan I. Sadreyev·bioRxiv·May 15, 2025
- Heterozygous Kmt2d loss diminishes enhancers to render medulloblastoma cells vulnerable to combinatory inhibition of lysine demethylation and oxidative phosphorylation
S. S. Dhar, C. Brown, … M. Lee·bioRxiv·Oct 29, 2023
- KMT2C and KMT2D amplify GRHL2-driven enhancer activation
Ryan M. Boileau, Kevin X. Chen, Robert H. Blelloch·bioRxiv·Mar 16, 2026
- DNMT1-Mediated Epigenetic Reprogramming Drives KMT2A Amplifications and Rearrangements
Madison A. Lineberger, Zach H. Gray, … Johnathan R. Whetstine·bioRxiv·Sep 22, 2026
- KDM5 inhibition offers a novel therapeutic strategy for the treatment of KMT2D mutant lymphomas
J. A. Heward, L. Koniali, … J. Fitzgibbon·bioRxiv·Jun 30, 2020